Engineering and Scientific Consulting Franchise Trading Below Intrinsic Value

Exponent, Inc. is a leading engineering and scientific consulting firm headquartered in Menlo Park, California. Founded in 1967, the company provides independent technical analysis to clients facing complex engineering, environmental, health, and regulatory challenges.

What the company does: Exponent's consultants investigate failures, assess product safety, support litigation, and advise on regulatory compliance. Engagements range from single-expert consultations to multi-year, multidisciplinary investigations.

How it makes money: Revenue is generated through time-and-materials billing, with rates varying by consultant seniority and specialization. The company operates through two reporting segments: Engineering and Other Scientific (roughly 80% of revenue) and Environmental and Health (roughly 20%). Litigation support and reactive failure analysis represent the largest revenue pools, followed by proactive consulting and regulatory work.

Customers: Clients include Fortune 500 corporations, law firms, insurance companies, and government agencies. No single client accounts for more than a few percent of revenue, providing significant diversification.

Scale: With a market cap of $3.3B, 47.55M shares outstanding, and a public float of 46.90M shares, Exponent is a mid-cap professional services firm. The company employs a large bench of technical staff and operates offices across the United States and in select international markets.

Near-term (next 12–24 months):

• Litigation activity: A steady pipeline of product liability and intellectual property disputes supports demand for expert testimony and technical analysis.
• Regulatory complexity: Increasing regulation in areas such as battery safety, medical devices, and environmental compliance drives proactive consulting engagements.
• Pricing: Modest annual rate increases, typically in the 3–5% range, provide a reliable revenue tailwind independent of volume.

Medium-term (3–5 years):

• Electrification and energy transition: Growth in electric vehicles, grid storage, and renewable energy creates new failure-analysis and safety-consulting demand.
• Artificial intelligence and software liability: Emerging disputes over AI-driven decisions and software failures represent a new and potentially large practice area.
• International expansion: Selective geographic growth, particularly in Europe and Asia, offers a long runway given the firm's currently U.S.-centric revenue base.
• Adjacent practice areas: Expansion into human factors, cybersecurity, and climate-risk consulting broadens the addressable market.

We model revenue growing at a 6–7% CAGR over the next three years, with EBITDA margins expanding 100–200 basis points as utilization improves.

The narrative is straightforward: revenue growth is driven by a mix of pricing (3–5% annually) and volume (2–3%), while margin expansion comes from operating leverage as utilization recovers. Capex remains low, consistent with an asset-light consulting model, and the dividend grows modestly in line with earnings. The key risk to this trajectory is a prolonged slowdown in litigation activity or a deterioration in utilization.

Market size: The global engineering and scientific consulting market is estimated at $50–60B annually, with the litigation-support and forensic-engineering subsegment representing roughly $8–12B. Exponent's addressable market continues to expand as regulatory complexity and technological risk increase.

Competitive positioning: Exponent's key differentiator is its multidisciplinary, independent platform. Unlike specialized boutique firms, Exponent can staff complex engagements with cross-functional teams, and its independence from manufacturing or insurance interests enhances its credibility as an expert witness.

Named comparables:

• ICF International (ICFI): A consulting firm focused on government and commercial clients; trades at a similar or slightly higher multiple but with lower margins.
• Huron Consulting Group (HURN): A healthcare and business consulting firm with a comparable asset-light model.
• CRA International (CRAI): A litigation and economic consulting firm that competes directly in the expert-testimony market.
• Forrester Research (FORR): A research and advisory firm with a subscription-like revenue model, though less directly comparable.

Exponent's premium valuation relative to some peers reflects its superior margin profile, low cyclicality, and strong balance sheet.

DCF discussion: Our base-case DCF assumes a 6.5% revenue CAGR over five years, EBITDA margins expanding to 25%, a 9% weighted average cost of capital (reflecting the company's low beta of 0.69 and net cash position), and a 2.5% terminal growth rate. This yields a fair value estimate in the low-to-mid $80s per share. A bear case (4% growth, flat margins) yields roughly $60, while a bull case (8% growth, 27% margins) yields north of $95.

Comparable-company multiples:

Exponent trades at a premium P/E to peers, justified by its higher margins and lower cyclicality, but the EV/EBITDA multiple of 15.0x is only modestly above the peer average, suggesting the premium is not excessive. We view the current price as offering an attractive entry point for long-term investors.

• Utilization risk: A decline in billable utilization, whether from softer demand or over-hiring, would pressure margins and earnings.
• Litigation cyclicality: While more stable than many end markets, litigation activity can slow during periods of economic uncertainty or following changes in legal frameworks.
• Key personnel dependence: Exponent's value is tied to its roster of highly credentialed experts; the loss of senior consultants or difficulty recruiting could impair growth.
• Competition: Boutique firms and larger consultancies continue to encroach on Exponent's practice areas, potentially pressuring pricing.
• Regulatory and legal changes: Shifts in liability standards, evidentiary rules, or environmental regulations could reduce demand for certain services.